These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


320 related items for PubMed ID: 17097377

  • 1. Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases.
    Dinh HV, McCormack C, Hall S, Prince HM.
    J Am Acad Dermatol; 2007 Jan; 56(1):148-53. PubMed ID: 17097377
    [Abstract] [Full Text] [Related]

  • 2. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab).
    Morrison LH.
    J Am Acad Dermatol; 2004 Nov; 51(5):817-9. PubMed ID: 15523367
    [Abstract] [Full Text] [Related]

  • 3. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
    Arin MJ, Engert A, Krieg T, Hunzelmann N.
    Br J Dermatol; 2005 Sep; 153(3):620-5. PubMed ID: 16120153
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rituximab as therapy for refractory polymyositis and dermatomyositis.
    Noss EH, Hausner-Sypek DL, Weinblatt ME.
    J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M, Anzaar F, Sobrin L, Foster CS.
    Ocul Immunol Inflamm; 2007 May; 15(2):99-104. PubMed ID: 17558834
    [Abstract] [Full Text] [Related]

  • 10. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients.
    Cooper MA, Willingham DL, Brown DE, French AR, Shih FF, White AJ.
    Arthritis Rheum; 2007 Sep; 56(9):3107-11. PubMed ID: 17763414
    [Abstract] [Full Text] [Related]

  • 11. A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy.
    Lui NL, Thumboo J, Fong KY.
    Int J Rheum Dis; 2009 Dec; 12(4):366-9. PubMed ID: 20374378
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.
    Albert D, Dunham J, Khan S, Stansberry J, Kolasinski S, Tsai D, Pullman-Mooar S, Barnack F, Striebich C, Looney RJ, Prak ET, Kimberly R, Zhang Y, Eisenberg R.
    Ann Rheum Dis; 2008 Dec; 67(12):1724-31. PubMed ID: 18250115
    [Abstract] [Full Text] [Related]

  • 17. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M, Isaji S, Mizuno S, Sakurai H, Uemoto S.
    Clin Transplant; 2007 Dec; 21(1):24-31. PubMed ID: 17302588
    [Abstract] [Full Text] [Related]

  • 18. Disseminated Nocardia brasiliensis infection: an unusual complication of immunosuppressive treatment for childhood dermatomyositis.
    Klein-Gitelman MS, Szer IS.
    J Rheumatol; 1991 Aug; 18(8):1243-6. PubMed ID: 1941833
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
    Ang GC, Werth VP.
    Arch Dermatol; 2005 Jul; 141(7):855-9. PubMed ID: 16027300
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.